Baldwin Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-200
Closed -$30.8K 1113
2024
Q2
$30.8K Hold
200
﹤0.01% 414
2024
Q1
$30.8K Hold
200
﹤0.01% 439
2023
Q4
$31.6K Hold
200
﹤0.01% 437
2023
Q3
$29.3K Hold
200
﹤0.01% 467
2023
Q2
$30.6K Hold
200
﹤0.01% 482
2023
Q1
$31K Hold
200
﹤0.01% 491
2022
Q4
$30.8K Hold
200
﹤0.01% 484
2022
Q3
$26K Hold
200
﹤0.01% 420
2022
Q2
$27K Hold
200
﹤0.01% 440
2022
Q1
$30K Hold
200
﹤0.01% 439
2021
Q4
$32K Hold
200
﹤0.01% 402
2021
Q3
$33K Hold
200
﹤0.01% 396
2021
Q2
$35K Hold
200
﹤0.01% 400
2021
Q1
$32K Hold
200
﹤0.01% 391
2020
Q4
$34K Hold
200
﹤0.01% 356
2020
Q3
$31K Hold
200
﹤0.01% 344
2020
Q2
$34K Hold
200
0.01% 337
2020
Q1
$26K Hold
200
﹤0.01% 347
2019
Q4
$30K Hold
200
﹤0.01% 370
2019
Q3
$25K Hold
200
﹤0.01% 378
2019
Q2
$28K Hold
200
﹤0.01% 366
2019
Q1
$30K Hold
200
﹤0.01% 356
2018
Q4
$25K Hold
200
﹤0.01% 359
2018
Q3
$32K Hold
200
﹤0.01% 356
2018
Q2
$28K Buy
+200
New +$27.5K ﹤0.01% 366

Other funds holding FBT

Baldwin Wealth Partners's FBT Position: Q3 2024 in Review

Baldwin Wealth Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2024, closing a stake of 200 shares — an estimated $30.8K sold.

Baldwin Wealth Partners first reported a position in FBT in Q2 2018 and held it in 25 quarters. The position peaked at $35K in Q2 2021. 257 funds tracked by Wall St. Rank hold FBT as of Q3 2024.

  • Baldwin Wealth Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2024 after selling out during the quarter.
  • Baldwin Wealth Partners sold 200 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2024, an estimated $30.8K.
  • Baldwin Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and held it in 25 quarters.
  • Baldwin Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $35K in Q2 2021.
  • 257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2024.

Based on Baldwin Wealth Partners's 13F filing for Q3 2024, filed 16 Oct 2024.